Cantabio Pharmaceuticals Inc (CTBO)
1.01
0.00 (0.00%)
USD |
OTCM |
Apr 26, 16:00
Cantabio Pharmaceuticals Total Liabilities (Quarterly): 2.215M for Dec. 31, 2018
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2018 | 2.215M |
| September 30, 2018 | 2.444M |
| June 30, 2018 | 2.488M |
| March 31, 2018 | 1.983M |
| December 31, 2017 | 1.827M |
| September 30, 2017 | 1.500M |
| June 30, 2017 | 1.137M |
| March 31, 2017 | 0.8874M |
| December 31, 2016 | 0.6073M |
| September 30, 2016 | 0.4568M |
| June 30, 2016 | 0.4463M |
| March 31, 2016 | 0.4219M |
| December 31, 2015 | 0.1885M |
| Date | Value |
|---|---|
| September 30, 2015 | 0.0408M |
| June 30, 2015 | 0.0353M |
| March 31, 2015 | 0.2187M |
| December 31, 2014 | 0.0044M |
| September 30, 2014 | 0.0193M |
| June 30, 2014 | 0.0062M |
| March 31, 2014 | 0.0066M |
| December 31, 2013 | 0.0333M |
| September 30, 2013 | 0.0168M |
| June 30, 2013 | 0.004M |
| March 31, 2013 | 0.0157M |
| December 31, 2012 | 0.002M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Q BioMed Inc | 9.906M |
| NVN Liquidation Inc | 82.62M |
| Affymax Inc | -- |
| Scopus BioPharma Inc | 11.00M |
| Statera BioPharma Inc | 22.92M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 0.3259M |
| Shareholders Equity (Quarterly) | -1.889M |